MedTrace Logo

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

NCT02247934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2016-02-09

No results posted yet for this study

Summary

The objectives of this qualitative study are to elicit concepts about symptoms that are important to patients with primary sclerosing cholangitis (PSC), as well as the key impacts of symptoms on patients' day-to-day functioning.

Conditions

  • Primary Sclerosing Cholangitis

Sponsors & Collaborators

Principal Investigators

  • Rob Myers, MD · Gilead Sciences

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02247934 on ClinicalTrials.gov